Aug. 3, 2020

Main Content

Peds gastro, pulmonary, microbiology fellows join faculty

Medical Center leadership is proud to announce the following additions to its faculty and leadership staff.

Mabel Camacho, M.D.

Portrait of Dr. Mabel Camacho

Dr. Mabel Camacho has recently joined the Pediatric Gastroenterology Division at UMMC as an assistant professor of pediatrics after having completed a pediatric gastroenterology fellowship at the Baylor College of Medicine at Children’s Hospital of San Antonio.

Upon receiving her M.D. cum laude from Pontificia Universidad Catolica Madre y Maestra, Dominican Republic, she completed a pediatric residency in the Bronx, New York. She completed her training in pediatric gastroenterology at the Baylor College of Medicine with an outstanding leadership award.

An active member of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and the American Academy of Pediatrics, Camacho is the author or co-author of articles in peer-reviewed professional publications and posters presented at scientific meetings internationally and has been invited for multiple oral presentations. Her research interests include diagnostic accuracy of imaging studies and exocrine pancreatic function testing for chronic pancreatitis in pediatric patients.

I. J. Frame, M.D., Ph.D.

Portrait of of Dr. Ithiel Frame

Dr. I. J. Frame, recently a medical microbiology fellow at the University of Texas Southwestern Medical Center, Dallas, has joined the Medical Center faculty as an assistant professor of pathology.

After receiving a Bachelor of Music with highest honors from the University of Colorado at Boulder in 2005, Frame earned a Master of Science in human nutrition at Columbia University in the city of New York in 2007, and a Master of Science in physiology and biophysics at the Albert Einstein College of Medicine of Yeshiva University in 2012. Frame entered the Medical Scientist Training Program at the Albert Einstein College of Medicine and obtained the M.D. and the Ph.D. in 2016. Frame completed clinical pathology residency training from 2016-19 and a medical microbiology fellowship from 2019-20 at UT-Southwestern.

The author or coauthor of 12 articles in peer-reviewed professional publications, eight presentations given at scientific conferences internationally and three book chapters, Frame has helped obtain two patents. Frame is an active member of the American Society for Microbiology, the American Society for Clinical Pathology and the College of American Pathologists, among other professional organizations.

Frame’s research interests include novel clinical diagnostics discovery, clinical diagnostic algorithms and pathogen metabolism.

Yanglin Guo, M.D.

Portrait of Yanglin Guo

Dr. Yanglin Guo, recently a pulmonary and critical care medicine fellow at UMMC, has joined the Medical Center faculty as an assistant professor of medicine.

After receiving a B.S. in chemistry from Vanderbilt University, Nashville, Tennessee, in 2010, Guo earned an M.D. with honors at Meharry Medical College, Nashville, in 2014. Guo then had residency training in internal medicine from 2014-17 and fellowship training in pulmonary and critical care medicine from 2017-20 at UMMC.

An active member of the Society of Critical Care Medicine, the American Thoracic Society, the American College of Chest Physicians, the Pulmonary Hypertension Association and the American College of Physicians, Guo has given two invited presentations and is the coauthor of a peer-reviewed scientific article, “Regulation of the Activity and Expression of Aryl Hydrocarbon Receptor by Ethanol in Mouse Hepatic Stellate Cells,” published in the journal Alcoholism: Clinical and Experimental Research. Guo also is the coauthor of a submitted manuscript, "A Multicenter Observational Cohort Study of Angiotensin II for Vasodilatory Shock," in consideration for publication in the Journal of Intensive Care Medicine. Guo has seven posters presented at scientific meetings nationally.

Guo’s current research interests include the use of novel vasopressors in refractory vasodilatory shock, pulmonary arterial hypertension and interventional pulmonology.